P2RX7 and pulmonary hypertension: On the contrary, treatment with a different P2X7 receptor antagonist, PKT100, did not alter right ventricular systolic pressure, but substantially improved survival in a mouse model of pulmonary hypertension [172], suggesting that further studies are needed to determine the possible role of P2X7 receptor antagonists in regulating blood pressure.